How Big Pharma is betting on electronics
06 February 2017 by Dr Guillaume Chansin
As the business model for commercializing new drugs becomes increasingly more difficult to sustain, the pharmaceutical industry is trying to reinvent itself. One bet is on electronic devices that could provide direct treatment of some chronic diseases. The race is on to find new materials that will be compatible for this new form of medicine.
Login or Register You are not logged in. For existing users, please login to learn more about this premium content. For new users, please register with idtechex.com or use the links below for more details about premium content from IDTechEx.
Subscription Benefits
A subscription from IDTechEx allows you to access our full body of research content on emerging technologies, including market, technology and company data, alongside direct engagement with our expert analysts.
Subscription content includes:
Subscription content includes:
- Market research reports
- Forecasts
- Premium articles
- Company profiles
- Industry digests
- Webinars
- Innovation maps
- Event summaries and write-ups